Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Current and emerging neuromodulation therapies for addiction: insight from pre-clinical studies.

Creed M.

Curr Opin Neurobiol. 2018 Apr;49:168-174. doi: 10.1016/j.conb.2018.02.015. Epub 2018 Mar 7. Review.

PMID:
29524847
2.

Glutamatergic Ventral Pallidal Neurons Modulate Activity of the Habenula-Tegmental Circuitry and Constrain Reward Seeking.

Tooley J, Marconi L, Alipio JB, Matikainen-Ankney B, Georgiou P, Kravitz AV, Creed MC.

Biol Psychiatry. 2018 Jun 15;83(12):1012-1023. doi: 10.1016/j.biopsych.2018.01.003. Epub 2018 Jan 12.

PMID:
29452828
3.

Periaqueductal efferents to dopamine and GABA neurons of the VTA.

Ntamati NR, Creed M, Achargui R, Lüscher C.

PLoS One. 2018 Jan 5;13(1):e0190297. doi: 10.1371/journal.pone.0190297. eCollection 2018.

4.

Drp1 Mitochondrial Fission in D1 Neurons Mediates Behavioral and Cellular Plasticity during Early Cocaine Abstinence.

Chandra R, Engeln M, Schiefer C, Patton MH, Martin JA, Werner CT, Riggs LM, Francis TC, McGlincy M, Evans B, Nam H, Das S, Girven K, Konkalmatt P, Gancarz AM, Golden SA, Iñiguez SD, Russo SJ, Turecki G, Mathur BN, Creed M, Dietz DM, Lobo MK.

Neuron. 2017 Dec 20;96(6):1327-1341.e6. doi: 10.1016/j.neuron.2017.11.037.

PMID:
29268097
5.

Toward a targeted treatment for addiction.

Creed MC.

Science. 2017 Aug 4;357(6350):464-465. doi: 10.1126/science.aao1197. No abstract available.

PMID:
28774920
6.

Alterations of M1 and M4 acetylcholine receptors in the genetically dystonic (dtsz) hamster and moderate antidystonic efficacy of M1 and M4 anticholinergics.

Hamann M, Plank J, Richter F, Bode C, Smiljanic S, Creed M, Nobrega JN, Richter A.

Neuroscience. 2017 Aug 15;357:84-98. doi: 10.1016/j.neuroscience.2017.05.051. Epub 2017 Jun 9.

PMID:
28596119
7.

Flow through a very porous obstacle in a shallow channel.

Creed MJ, Draper S, Nishino T, Borthwick AGL.

Proc Math Phys Eng Sci. 2017 Apr;473(2200):20160672. doi: 10.1098/rspa.2016.0672. Epub 2017 Apr 26.

8.

Temporally precise labeling and control of neuromodulatory circuits in the mammalian brain.

Lee D, Creed M, Jung K, Stefanelli T, Wendler DJ, Oh WC, Mignocchi NL, Lüscher C, Kwon HB.

Nat Methods. 2017 May;14(5):495-503. doi: 10.1038/nmeth.4234. Epub 2017 Apr 3.

PMID:
28369042
9.

Cocaine Exposure Enhances the Activity of Ventral Tegmental Area Dopamine Neurons via Calcium-Impermeable NMDARs.

Creed M, Kaufling J, Fois GR, Jalabert M, Yuan T, Lüscher C, Georges F, Bellone C.

J Neurosci. 2016 Oct 19;36(42):10759-10768.

10.

Modulating Morphine Context-Induced Drug Memory With Deep Brain Stimulation: More Research Questions by Lowering Stimulation Frequencies?

Creed M, Bonci A, Leggio L.

Biol Psychiatry. 2016 Nov 1;80(9):647-649. doi: 10.1016/j.biopsych.2016.08.022. No abstract available.

11.

Convergence of Reinforcing and Anhedonic Cocaine Effects in the Ventral Pallidum.

Creed M, Ntamati NR, Chandra R, Lobo MK, Lüscher C.

Neuron. 2016 Oct 5;92(1):214-226. doi: 10.1016/j.neuron.2016.09.001. Epub 2016 Sep 22.

12.

Assessing Fidelity to Suicide Reporting Guidelines in Canadian News Media: The Death of Robin Williams.

Creed M, Whitley R.

Can J Psychiatry. 2017 May;62(5):313-317. doi: 10.1177/0706743715621255. Epub 2016 Sep 6.

13.

Optogenetic dissection of neural circuitry: from synaptic causalities to blue prints for novel treatments of behavioral diseases.

Lüscher C, Pascoli V, Creed M.

Curr Opin Neurobiol. 2015 Dec;35:95-100. doi: 10.1016/j.conb.2015.07.005. Epub 2015 Aug 8. Review.

PMID:
26264408
14.

Deep brain stimulation of the subthalamic nucleus preferentially alters the translational profile of striatopallidal neurons in an animal model of Parkinson's disease.

Visanji NP, Kamali Sarvestani I, Creed MC, Shams Shoaei Z, Nobrega JN, Hamani C, Hazrati LN.

Front Cell Neurosci. 2015 Jun 9;9:221. doi: 10.3389/fncel.2015.00221. eCollection 2015.

15.

Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings.

Willig LK, Petrikin JE, Smith LD, Saunders CJ, Thiffault I, Miller NA, Soden SE, Cakici JA, Herd SM, Twist G, Noll A, Creed M, Alba PM, Carpenter SL, Clements MA, Fischer RT, Hays JA, Kilbride H, McDonough RJ, Rosterman JL, Tsai SL, Zellmer L, Farrow EG, Kingsmore SF.

Lancet Respir Med. 2015 May;3(5):377-87. doi: 10.1016/S2213-2600(15)00139-3. Epub 2015 Apr 27.

16.

Addiction therapy. Refining deep brain stimulation to emulate optogenetic treatment of synaptic pathology.

Creed M, Pascoli VJ, Lüscher C.

Science. 2015 Feb 6;347(6222):659-64. doi: 10.1126/science.1260776.

17.

Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders.

Soden SE, Saunders CJ, Willig LK, Farrow EG, Smith LD, Petrikin JE, LePichon JB, Miller NA, Thiffault I, Dinwiddie DL, Twist G, Noll A, Heese BA, Zellmer L, Atherton AM, Abdelmoity AT, Safina N, Nyp SS, Zuccarelli B, Larson IA, Modrcin A, Herd S, Creed M, Ye Z, Yuan X, Brodsky RA, Kingsmore SF.

Sci Transl Med. 2014 Dec 3;6(265):265ra168. doi: 10.1126/scitranslmed.3010076.

18.

Effects of high-frequency stimulation of the nucleus accumbens on the development and expression of ethanol sensitization in mice.

Nona CN, Creed MC, Hamani C, Nobrega JN.

Behav Pharmacol. 2015 Feb;26(1-2):184-92. doi: 10.1097/FBP.0000000000000033.

PMID:
24642732
19.

Changes in brain functional connectivity after chronic haloperidol in rats: a network analysis.

Wheeler AL, Creed MC, Voineskos AN, Nobrega JN.

Int J Neuropsychopharmacol. 2014 Aug;17(8):1129-38. doi: 10.1017/S1461145714000042. Epub 2014 Feb 14.

PMID:
24524273
20.

VTA GABA neurons modulate specific learning behaviors through the control of dopamine and cholinergic systems.

Creed MC, Ntamati NR, Tan KR.

Front Behav Neurosci. 2014 Jan 22;8:8. doi: 10.3389/fnbeh.2014.00008. eCollection 2014. Review.

21.

Drug-evoked synaptic plasticity: beyond metaplasticity.

Creed MC, Lüscher C.

Curr Opin Neurobiol. 2013 Aug;23(4):553-8. doi: 10.1016/j.conb.2013.03.005. Epub 2013 Apr 6. Review.

PMID:
23571119
22.

Deep brain stimulation of the subthalamic nucleus increases premature responding in a rat gambling task.

Aleksandrova LR, Creed MC, Fletcher PJ, Lobo DS, Hamani C, Nobrega JN.

Behav Brain Res. 2013 May 15;245:76-82. doi: 10.1016/j.bbr.2013.02.011. Epub 2013 Feb 19.

PMID:
23434606
23.

The role of serotonin in the antidyskinetic effects of deep brain stimulation: focus on antipsychotic-induced motor symptoms.

Creed MC, Nobrega JN.

Rev Neurosci. 2013;24(2):153-66. doi: 10.1515/revneuro-2012-0083. Review.

PMID:
23399586
24.
25.

Effects of repeated deep brain stimulation on depressive- and anxiety-like behavior in rats: comparing entopeduncular and subthalamic nuclei.

Creed MC, Hamani C, Nobrega JN.

Brain Stimul. 2013 Jul;6(4):506-14. doi: 10.1016/j.brs.2012.09.012. Epub 2012 Oct 13.

PMID:
23088853
26.
27.

Effects of dose ranging of adenosine infusion on electrocardiographic findings during and after general anesthesia.

Sun YX, Habib AS, Wenger T, Gratz I, Glick D, Adsumelli R, Creed MR, Gan TJ.

J Anesth. 2012 Oct;26(5):689-95. doi: 10.1007/s00540-012-1418-2. Epub 2012 Jun 3.

PMID:
22661123
28.

Early gene mapping after deep brain stimulation in a rat model of tardive dyskinesia: comparison with transient local inactivation.

Creed MC, Hamani C, Nobrega JN.

Eur Neuropsychopharmacol. 2012 Jul;22(7):506-17. doi: 10.1016/j.euroneuro.2011.11.004. Epub 2011 Dec 7.

PMID:
22153973
29.

Haematological changes at altitude.

Wheatley K, Creed M, Mellor A.

J R Army Med Corps. 2011 Mar;157(1):38-42. Review.

PMID:
21465909
30.

Rolapitant for the prevention of postoperative nausea and vomiting: a prospective, double-blinded, placebo-controlled randomized trial.

Gan TJ, Gu J, Singla N, Chung F, Pearman MH, Bergese SD, Habib AS, Candiotti KA, Mo Y, Huyck S, Creed MR, Cantillon M; Rolapitant Investigation Group.

Anesth Analg. 2011 Apr;112(4):804-12. doi: 10.1213/ANE.0b013e31820886c3. Epub 2011 Mar 8.

PMID:
21385988
31.

Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications.

Creed MC, Milgram NW.

Age (Dordr). 2010 Sep;32(3):365-84. doi: 10.1007/s11357-010-9142-z. Epub 2010 Apr 20. Review.

32.

Deep brain stimulation of the subthalamic or entopeduncular nucleus attenuates vacuous chewing movements in a rodent model of tardive dyskinesia.

Creed M, Hamani C, Nobrega JN.

Eur Neuropsychopharmacol. 2011 May;21(5):393-400. doi: 10.1016/j.euroneuro.2010.06.012. Epub 2010 Jul 10.

PMID:
20624675
33.

Phase 2, double-blind, placebo-controlled, dose-response trial of intravenous adenosine for perioperative analgesia.

Habib AS, Minkowitz H, Osborn T, Ogunnaike B, Candiotti K, Viscusi E, Gu J, Creed MR, Gan TJ; Adenosine Study Group.

Anesthesiology. 2008 Dec;109(6):1085-91. doi: 10.1097/ALN.0b013e31818db88c.

PMID:
19034105
34.

Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo.

Hill RP, Lubarsky DA, Phillips-Bute B, Fortney JT, Creed MR, Glass PS, Gan TJ.

Anesthesiology. 2000 Apr;92(4):958-67.

PMID:
10754614
35.

Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled multicenter trial.

Kovac AL, O'Connor TA, Pearman MH, Kekoler LJ, Edmondson D, Baughman VL, Angel JJ, Campbell C, Jense HG, Mingus M, Shahvari MB, Creed MR.

J Clin Anesth. 1999 Sep;11(6):453-9.

PMID:
10526822
36.

Intravenous ondansetron for the control of opioid-induced nausea and vomiting. International S3AA3013 Study Group.

Sussman G, Shurman J, Creed MR, Larsen LS, Ferrer-Brechner T, Noll D, Allegra J, Montgomery R, Schreck D, Grafstein E, Ramalanjaona G, Patel V, Ducharme J, Ortenwall P, Foster E, Ames M.

Clin Ther. 1999 Jul;21(7):1216-27.

PMID:
10463519
37.

A Comparison of Oral Ondansetron and Intravenous Granisetron for the Prevention of Nausea and Emesis Associated with Cisplatin-Based Chemotherapy.

Spector JI, Lester EP, Chevlen EM, Sciortino D, Harvey JH, Whaley W, Madajewicz S, Isaacs R, Homesley HD, Yee S, Beck TM, Tchekmedyian NS, Crawford KH, Ames M, Creed MR.

Oncologist. 1998;3(6):432-438.

38.

A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups.

Fortney JT, Gan TJ, Graczyk S, Wetchler B, Melson T, Khalil S, McKenzie R, Parrillo S, Glass PS, Moote C, Wermeling D, Parasuraman TV, Duncan B, Creed MR.

Anesth Analg. 1998 Apr;86(4):731-8.

PMID:
9539593
39.

Single-dose ondansetron prevents postoperative vomiting in pediatric outpatients.

Patel RI, Davis PJ, Orr RJ, Ferrari LR, Rimar S, Hannallah RS, Cohen IT, Colingo K, Donlon JV, Haberkern CM, McGowan FX, Prillaman BA, Parasuraman TV, Creed MR.

Anesth Analg. 1997 Sep;85(3):538-45.

PMID:
9296406
40.

Intravenous ondansetron for postsurgical opioid-induced nausea and vomiting. S3A-255 Study Group.

Rung GW, Claybon L, Hord A, Patel C, Kallgren M, Koppel J, Benedetti C, Creed M, Asgharian A, Bryson J.

Anesth Analg. 1997 Apr;84(4):832-8.

PMID:
9085967
41.

Intravenous ondansetron in established postoperative emesis in children. S3A-381 Study Group.

Khalil S, Rodarte A, Weldon BC, Weinstein M, Grunwald Z, Ginsberg B, Kaye R, Otto A, Wheeler M, Lawhorn CD, Prillaman BA, Creed M.

Anesthesiology. 1996 Aug;85(2):270-6.

PMID:
8712441
42.

Tight glucose control results in normal perinatal outcome in 150 patients with gestational diabetes.

Thompson DM, Dansereau J, Creed M, Ridell L.

Obstet Gynecol. 1994 Mar;83(3):362-6.

PMID:
8127526
43.

To screen or not to screen.

Thompson DM, Wylie B, Bryer-Ash M, Creed M, Jenkins L, Kozak S, Young S, Lucci D, Sanghera R, Wheeler A.

CMAJ. 1993 Jan 1;148(1):12-3; author reply 13-4. No abstract available.

Supplemental Content

Support Center